Return to homepagePandemic Pact

Corona-Biobank Observes Consequential Damage

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Principal Investigator

    Prof Dr med and PD Dr med Maria Vehreschild, Timo Wolf

  • Research Location

    Germany

  • Lead Research Institution

    Frankfurt University Hospital

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Prof. Maria Vehreschild collects samples and clinical data from COVID-19 patients - even after their recovery - in an infectious biobank at the university hospital; the Goethe-Corona-Fonds makes personnel resources available here. The biological samples and information from the biobank help researchers better understand acute disease processes and long-term effects of the disease. These data are an important basis for the development of diagnostics, drugs, vaccinations and therapies. Prof. Vehreschild supplies vaccination and drug researchers throughout Germany with their samples; in the meantime, their database has been incorporated into a pan-German biobank. "I am committed to clinical research so that new drugs can quickly find their way to our patients."